SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-21-000549
Filing Date
2021-02-12
Accepted
2021-02-12 17:13:57
Documents
3
Period of Report
2021-02-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cns_8k.htm 8-K 21989
2 CAPITAL ON DEMAND SALES AGREEMENT cns_ex0101.htm EX-1.1 273254
3 OPINION OF SCHIFF HARDIN LLP cns_ex0501.htm EX-5.1 11157
  Complete submission text file 0001683168-21-000549.txt   307540
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 21629586
SIC: 2834 Pharmaceutical Preparations